Literature DB >> 16673195

Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.

Chinazo O Cunningham1, Nancy L Sohler, Kate McCoy, Hillary V Kunins.   

Abstract

BACKGROUND AND OBJECTIVES: Opioid abuse and dependence are increasing. Pharmacotherapy with an opioid agonist reduces adverse consequences of opioid dependency. Physicians can now prescribe buprenorphine for opioid dependency in the primary care setting. This study assessed primary care providers' attitudes and beliefs about opioid addiction treatment with buprenorphine.
METHODS: Ninety-nine resident and attending physicians from six ambulatory clinics associated with a university hospital were interviewed with an adapted questionnaire eliciting attitudes and beliefs about opioid addiction treatment options, including buprenorphine.
RESULTS: While only 37.8% of respondents believed primary care providers should prescribe buprenorphine, and 35.7% reported interest in prescribing buprenorphine, 72.1% were willing to prescribe it with training and support. Common training/support needs were buprenorphine education/training (83.8%), available consultation (19.2%), and on-site counselors (18.2%). The most frequent reasons for not prescribing buprenorphine were lack of knowledge or training (47.5%) and lack of time (25.3%). Physicians involved in primary care-oriented programs (versus non-primary care programs) were more likely to have positive attitudes regarding buprenorphine.
CONCLUSIONS: Most physicians would be willing to prescribe buprenorphine with proper training and support. Barriers and training/support needs must be addressed to develop effective opioid addiction treatment programs in the primary care setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673195

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  22 in total

1.  Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.

Authors:  Joji Suzuki; Hilary S Connery; Tatyana V Ellison; John A Renner
Journal:  Am J Addict       Date:  2014-07-25

Review 2.  Training physicians to treat substance use disorders.

Authors:  Soteri Polydorou; Erik W Gunderson; Frances R Levin
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

3.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

4.  A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.

Authors:  Osama M Ahmed; Jodi A Mao; Stephen R Holt; Kathryn Hawk; Gail D'Onofrio; Shara Martel; Edward R Melnick
Journal:  J Subst Abuse Treat       Date:  2019-05-07

5.  Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.

Authors:  Traci R Rieckmann; Nicholas Gideonse; Amanda Risser; Jennifer E DeVoe; Amanda J Abraham
Journal:  J Behav Health Serv Res       Date:  2017-07       Impact factor: 1.505

6.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

7.  Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.

Authors:  Helena Hansen; Carole Siegel; Joseph Wanderling; Danae DiRocco
Journal:  Drug Alcohol Depend       Date:  2016-05-04       Impact factor: 4.492

Review 8.  Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.

Authors:  E Jennifer Edelman; David A Fiellin
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

9.  The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Authors:  James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
Journal:  J Gen Intern Med       Date:  2010-05-11       Impact factor: 5.128

10.  HIV provider endorsement of primary care buprenorphine treatment: a vignette study.

Authors:  Hillary V Kunins; Nancy L Sohler; Robert J Roose; Chinazo O Cunningham
Journal:  Fam Med       Date:  2009 Nov-Dec       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.